comparemela.com

Latest Breaking News On - French medtech - Page 9 : comparemela.com

CARMAT Presented Its Progress on the EFICAS Clinical Study at the 36th Journées de La Pitié in Paris

PARIS, October 23, 2023 Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces that it has presented its progress on the EFICAS clinical trial at the 36th "Journées de La Pitié" national conference on heart and lung transplantation and circulatory assistance, organized by the cardi

CARMAT Completes a €7 Million Capital Increase With Several Historical Financial Shareholders

CARMAT Completes a €7 Million Capital Increase With Several Historical Financial Shareholders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Theraclion Announces Its Half-year Financial Results for 2023 and Provides an Update on the Execution of Its Strategy

Theraclion Announces Its Half-year Financial Results for 2023 and Provides an Update on the Execution of Its Strategy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.